Clinical Trial Update: Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral desensitization to peanut in peanut-allergic individuals using characterized peanut allergen (OIT) has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• characterized peanut allergen oral immunotherapy

Snippet

Sponsor: Aimmune Therapeutics, Inc. | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED | Results posted: 2021-11-02